These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 36615434)
1. Insights on Ferroptosis and Colorectal Cancer: Progress and Updates. Hu B; Yin Y; Li S; Guo X Molecules; 2022 Dec; 28(1):. PubMed ID: 36615434 [TBL] [Abstract][Full Text] [Related]
2. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Wang Y; Zhang Z; Sun W; Zhang J; Xu Q; Zhou X; Mao L Biomed Pharmacother; 2022 Sep; 153():113524. PubMed ID: 36076606 [TBL] [Abstract][Full Text] [Related]
3. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771 [No Abstract] [Full Text] [Related]
4. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer. Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538 [TBL] [Abstract][Full Text] [Related]
5. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy. Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE Cells; 2023 Jun; 12(12):. PubMed ID: 37371096 [TBL] [Abstract][Full Text] [Related]
6. Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation. Liu S; Yue M; Lu Y; Wang Y; Luo S; Liu X; Jiang J Apoptosis; 2024 Feb; 29(1-2):86-102. PubMed ID: 37752371 [TBL] [Abstract][Full Text] [Related]
7. Ferroptosis in colorectal cancer: a future target? Yan H; Talty R; Aladelokun O; Bosenberg M; Johnson CH Br J Cancer; 2023 Apr; 128(8):1439-1451. PubMed ID: 36703079 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression. Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745 [TBL] [Abstract][Full Text] [Related]
9. Targeting Ferroptosis: Small-molecule Inducers as Novel Anticancer Agents. Jin S; Wang H; Zhang Z; Yan M Anticancer Agents Med Chem; 2024 Oct; ():. PubMed ID: 39411969 [TBL] [Abstract][Full Text] [Related]
10. Ferroptosis: the balance between death and survival in colorectal cancer. Fan S; Zhou L; Zhang W; Wang D; Tang D Int J Biol Sci; 2024; 20(10):3773-3783. PubMed ID: 39113707 [TBL] [Abstract][Full Text] [Related]
11. Review of ferroptosis in colorectal cancer: Friends or foes? Wu Z; Fang ZX; Hou YY; Wu BX; Deng Y; Wu HT; Liu J World J Gastroenterol; 2023 Jan; 29(3):469-486. PubMed ID: 36688016 [TBL] [Abstract][Full Text] [Related]
12. Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates. Yang F; Sun SY; Wang S; Guo JT; Liu X; Ge N; Wang GX World J Gastrointest Oncol; 2022 Jan; 14(1):1-18. PubMed ID: 35116100 [TBL] [Abstract][Full Text] [Related]
13. Identification of a ferroptosis-related gene signature for prognosis prediction in colorectal cancer patients and relationship with vitamin D. Guo S; Zhao W; Zhang T; Li S; Guo J; Liu L J Steroid Biochem Mol Biol; 2023 Mar; 227():106234. PubMed ID: 36572352 [TBL] [Abstract][Full Text] [Related]
14. USP11-mediated LSH deubiquitination inhibits ferroptosis in colorectal cancer through epigenetic activation of CYP24A1. Duan J; Huang D; Liu C; Lv Y; Zhang L; Chang F; Zeng X; Li L; Wang W; Shao G Cell Death Dis; 2023 Jul; 14(7):402. PubMed ID: 37414755 [TBL] [Abstract][Full Text] [Related]
15. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer. Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629 [TBL] [Abstract][Full Text] [Related]
16. IL6ST: A Novel Therapeutic Target for Managing and Treating Colorectal Cancer Via Ferroptosis. Zhao K; He B; Xue K; Cao B; Ren K; Jin Y; Rong S; Wei L; Wei H Turk J Gastroenterol; 2024 Jun; 35(9):690-698. PubMed ID: 39344518 [TBL] [Abstract][Full Text] [Related]
17. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms. Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509 [TBL] [Abstract][Full Text] [Related]
18. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer. Sui X; Zhang R; Liu S; Duan T; Zhai L; Zhang M; Han X; Xiang Y; Huang X; Lin H; Xie T Front Pharmacol; 2018; 9():1371. PubMed ID: 30524291 [TBL] [Abstract][Full Text] [Related]
19. Auriculasin enhances ROS generation to regulate colorectal cancer cell apoptosis, ferroptosis, oxeiptosis, invasion and colony formation. Wang CX; Chen LH; Zhuang HB; Shi ZS; Chen ZC; Pan JP; Hong ZS Biochem Biophys Res Commun; 2022 Jan; 587():99-106. PubMed ID: 34872005 [TBL] [Abstract][Full Text] [Related]
20. Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. Cheng X; Zhao F; Ke B; Chen D; Liu F Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]